# Smiths Group plc Sustainable growth driven by John Crane, Flex-Tek and Smiths Interconnect

- Link: https://www.directorstalkinterviews.com/smiths-group-plc-sustainable-growth-driven-by-john-crane-flex-tek-and-smiths-interconnect/412770431
- Published: 2019-03-22T07:36:10+00:00
- Author: Charlotte Edwards

**[Smiths Group plc](https://www.directorstalkinterviews.com/ftse-company/smiths-group/smin.l)**(
LON:SMIN), today announced interim results for the half year ended 31 January 2019

**Highlights**

· Delivering further good growth:

o Underlying revenue up 2% to £1,573m; up 3% excluding Smiths Medical. Reported 
revenue up 2% driven by good growth in John Crane, Flex-Tek and Smiths Interconnect.

· Focused on operational excellence:

o Underlying headline operating profit down (2)%; up 2% excluding Smiths Medical.
Reported headline operating profit down (1)%, with favourable foreign exchange translation.

o The difference between headline and statutory operating are non-headline items
as defined in note 3 to the accounts, of which the largest constituent is the Guaranteed
Minimum Pensions (‘GMP’) equalisation.

· Strong financial framework:

o Continued strong balance sheet, net debt to EBITDA 1.5x.

o Cash conversion of 74%, temporarily impacted by inventory build for orders due
for delivery in H2. Cash conversion is expected to be much stronger for the year
overall.

· Further value creative investment:

o Continued investment for sustainable growth with cash R&D at 5.1% of sales (H1
2018: 4.6%).

o Further progress on portfolio optimisation:

§ Flex-Tek’s acquisition of United Flexible for $345m completed in February 2019.

§ Sold two non-core Smiths Medical businesses for a combined consideration of c.
£30m.

· Plans announced for the separation of Smiths Medical, to create two stronger, 
industry-leading companies.

· FY2019 outlook reaffirmed.

> **Andy Reynolds Smith, Group Chief Executive, commented:**
> “Smiths delivered another good performance in the first half with sustainable 
> growth driven by John Crane, Flex-Tek and Smiths Interconnect. The strong results
> from these divisions were partly offset by the anticipated decline in Smiths Medical
> and the timing of deliveries in Smiths Detection, with both on track to deliver
> growth in the second half.
> Today we have announced our plans for the separation of Smiths Medical to create
> two stronger companies each focusing on accelerating the execution of their plans
> and maximising the opportunities in their respective markets.
> We reaffirm our outlook for 2019. We expect to continue to deliver sustainable
> underlying revenue growth of at least 2%, underpinned by current trading of our
> four industrial technology divisions and by the increasing contribution from new
> product launches in Smiths Medical.”

Share on:
